Isomorphic Labs pockets $5B to push its AI-designed drugs into human trials
Isomorphic Labs just raised $5 billion in a Series C, co-led by Greenoaks and Sequoia Capital, to move its AI-designed drug candidates toward clinical trials. The DeepMind spinout says its engine has produced positive preclinical results in oncology and immunology — and it's already working with Eli Lilly, Novartis and J&J.
- Original source: techcrunch.com.
- The source published it on Nov 17, 2026 at 2:50 PM.
- No second outlet has reported it yet. Treat it as a single-source claim.
Isomorphic Labs has raised $5 billion in a Series C round, funding its push to get drug candidates into clinical trials. Greenoaks and Sequoia Capital co-led, with Andreessen Horowitz joining as a new investor. Every existing backer re-upped too: Alphabet's GV and CapitalG, Thrive Capital, MGX, Temasek and the UK Sovereign AI Fund.
The cash lands roughly six months after the London lab's $2.1 billion Series B in May. Isomorphic says it will spend it on its drug-design engine and on expanding into more types of medicine. The company didn't disclose a valuation this time, though Bloomberg reported earlier this month it was seeking funding at a $50 billion valuation.
The platform runs simulation AI models across multiple areas of chemistry to design drugs, building on DeepMind's AlphaFold protein-folding breakthrough. Isomorphic says the program has delivered positive preclinical results in oncology and immunology. It has already signed deals with pharma heavyweights Eli Lilly, Novartis and Johnson & Johnson.
This is Isomorphic's first raise since founder and CEO Demis Hassabis stepped back from running DeepMind to focus on drug discovery, shifting into a chairman role there. Hassabis and then-DeepMind director John Jumper won the Nobel Prize in chemistry for AlphaFold, which predicts a protein's 3D structure from its genetic sequence alone.
TopicsIsomorphic Labs · DeepMind · Demis Hassabis · Greenoaks · Sequoia Capital · Andreessen Horowitz · Eli Lilly · Novartis
Source: techcrunch.com
Written by AI from verified reporting.
More stories
- Tech & AI cnbc.com Caught by @intan.lestari99 0 viewsJensen Huang to Face House Foreign Affairs Panel Dec. 1, Nvidia Lawyer Set for Dec. 2
- Tech & AI thedefiant.io 0 viewsAMD Closes Taalas Buy, Betting on Chips Built for One AI Model
- Tech & AI x.com 1 viewGoogle and Amazon to hold 28% of Anthropic combined once it goes public
- Tech & AI breakingthenews.net 1 viewIreland pushes X's Grok to halt data collection

